View Single Post
Old 03-24-2017, 09:12 PM
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

Quote:
Originally Posted by jeffreyn View Post
However, as reported in another research paper [2], in (all?) PWPs the c-Abl enzyme interferes with the normal operation of Parkin.

[1] Matheoud et al. (2016) Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation, Cell 166, 314-327, doi: 10.1016/j.cell.2016.05.039.

[2] Brahmachari et al. (2016) Activation of tyrosine kinase c-Abl contributes to a-synuclein-induced neurodegeneration. J Clin Invest. doi: 10.1172/JCI85456.
U)

You've just described the theory of why c-Abl inhibitors (e.g. Nilotinib) may be neuroprotective.

Last edited by Tupelo3; 03-24-2017 at 09:48 PM.
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (03-24-2017)